Sharon Longhurst
Directeur/Bestuurslid bij IDOGEN AB (PUBL)
Actieve functies van Sharon Longhurst
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IDOGEN AB (PUBL) | Directeur/Bestuurslid | 12-05-2020 | - |
| Independent Dir/Board Member | 12-05-2020 | - | |
| ELICERA THERAPEUTICS AB | Directeur/Bestuurslid | 01-01-2024 | - |
| Independent Dir/Board Member | 01-01-2024 | - |
Loopbaan van Sharon Longhurst
Eerdere bekende functies van Sharon Longhurst
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 01-10-2021 | 01-08-2023 |
| MENDUS AB | Corporate Officer/Principal | - | - |
Opleiding van Sharon Longhurst
| University of Warwick | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Statistieken
Internationaal
| Zweden | 4 |
| Verenigd Koninkrijk | 3 |
| Nederland | 2 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| MENDUS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Beurs
- Insiders
- Sharon Longhurst
- Ervaring
